ClinicalTrials.Veeva

Menu

Influence of Neuromuscular Block on Mask Ventilation

K

Kreiskrankenhaus Dormagen

Status

Completed

Conditions

Effect of a Neuromuscular Block on Ventilation

Treatments

Drug: rocuronium

Study type

Interventional

Funder types

Other

Identifiers

NCT01849211
diffmask

Details and patient eligibility

About

Difficult mask ventilation might lead to a life-threatening situation, if endotracheal intubation is also impossible and neuromuscular blocking agents (NMBA) inhibit spontaneous ventilation. However, controversies exist if NMBA improve or impede face mask ventilation. Therefore, the effect of NMBAs on mask ventilation is assessed in patients with predictors for difficult face mask ventilation.

Enrollment

120 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with risk factors for difficult face mask ventilation
  • Patients scheduled for general anaesthesia with endotracheal intubation

Exclusion criteria

  • Increased Risk for pulmonary aspiration
  • scheduled for awake fiberoptic intubation
  • pregnancy

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

120 participants in 1 patient group

neuromuscular block
Other group
Treatment:
Drug: rocuronium

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems